Literature DB >> 933148

Studies on Campylobacter sputorum subspecies Mucosalis.

G H Lawson, A C Rowland, L Roberts.   

Abstract

Catalase-negative vibrios can be isolated in large numbers from the affected intestinal mucosa of pigs suffering from a range of porcine enteropathies in which the mucosa has an adenomatous component. These vibrios cannot be distinguished from strains of Campylobacter sputorum subsp. mucosalis. The resemblance between these bacteria strengthens the case already made on morphological evidence that these enteropathies have a common origin. Catalase-negative vibrios have also been isolated from the mouth and faeces of pigs. Some of these conform to the criteria established for the mucosalis subspecies but others can be differentiated from it. An antigenic analysis shows that strains of the mucosalis subspecies are closely related antigenically, but that differences may allow separation of strains.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 933148     DOI: 10.1099/00222615-9-2-163

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  3 in total

1.  30 years of campylobacters: biochemical characteristics and a biotyping proposal for Campylobacter jejuni.

Authors:  G A Hébert; D G Hollis; R E Weaver; M A Lambert; M J Blaser; C W Moss
Journal:  J Clin Microbiol       Date:  1982-06       Impact factor: 5.948

Review 2.  Proliferative hemorrhagic enteropathy in swine: an outbreak and review of the literature.

Authors:  W D Yates; E G Clark; A D Osborne; C C Enweani; O M Radostits; A Theede
Journal:  Can Vet J       Date:  1979-10       Impact factor: 1.008

3.  Biological roles of the O-methyl phosphoramidate capsule modification in Campylobacter jejuni.

Authors:  Lieke B van Alphen; Cory Q Wenzel; Michele R Richards; Christopher Fodor; Roger A Ashmus; Martin Stahl; Andrey V Karlyshev; Brendan W Wren; Alain Stintzi; William G Miller; Todd L Lowary; Christine M Szymanski
Journal:  PLoS One       Date:  2014-01-30       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.